Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

163.96
Delayed Data
As of Sep 22
 +4.17 / +2.61%
Today’s Change
95.14
Today|||52-Week Range
164.60
+45.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues183.6M230.3M329.5M445.3M
 
 
 
 
 
Cost of Goods Sold34.8M37.2M47.1M64.4M
 
 
 
 
 
Depreciation And Amortization2.5M2.8M3.3M6.2M
 
 
 
 
 
 
Operating ExpensesGross Income146.3M190.4M279.1M374.7M
 
 
 
 
 
General Expenses131.8M160.1M213.0M282.9M
 
 
 
 
 
Research And Development30.7M35.5M48.7M64.8M
 
 
 
 
 
Total Operating Expenses169.1M200.0M263.4M353.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.6M30.3M66.2M91.7M
 
 
 
 
 
Extraordinary Charge-6.2M-1.6M-1.1M-1.6M
 
 
 
 
 
Other Expenses49.0K-97.0K339.0K-349.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income8.5M28.8M65.8M91.3M
 
 
 
 
 
Income Taxes-1.2M-84.9M-27.7M-39.2M
 
 
 
 
 
Net Income7.4M113.7M38.1M52.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.3M40.6M42.2M43.2M
 
 
 
 
 
Shares To Calculate EPS Diluted41.6M42.9M44.9M44.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.18$2.65$0.85$1.17
 
 
 
 
 
EPS Diluted$0.18$2.65$0.85$1.17